Atrial remodelling: Evolving concepts

Indian Pacing and Electrophysiology Journal

Volumn 3, Issue 2, 2003, Pages 81-87

  Biffi, Mauro ^a   Boriani, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM ION; DILTIAZEM; DOFETILIDE; ENALAPRIL; HYDRALAZINE; MIBEFRADIL; PLACEBO; VERAPAMIL;

ADAPTATION; ANTIARRHYTHMIC ACTIVITY; CARDIOVERSION; CLINICAL PRACTICE; DRUG EFFICACY; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART RATE; HEART STRESS; HUMAN; NONHUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; RECURRENT DISEASE; REVIEW; SINUS RHYTHM;

EID: 3242772971     PISSN: 09726292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Attuel P, et al. Failure in the rate adaptation of the atrial refractory periods: new parameter to assess atrial vulnerability. PACE 1984;7:1382.
2. Boutjdir M, et al. Inhomogeneity of cellular refractoriness in human atrium: factor or arrhythmia ? PACE 1986;9(II):1095-1100
3. Nattel S, et al. Electrophysiological remodeling: are ion channel static players or dynamic movers ? J Cardiovasc Electrophysiol 1999;10:1553-1556
4. Nattel S, et al. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation. Cardiovasc Res 1999;42:298-308
5. Van Wagoner, et al. Atrial L-type Ca++ currents and human atrial fibrillation. Circ Res 1999;85:428-436
6. Yue L, et al. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ Res 1997;81:512-525
7. Yue L, et al. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation. Circ Res 1999;84:776-784
8. Wijffels MCEF, et al. Atrial fibrillation begets atrial fibrillation. Circulation 1995;92:1954-1968
9. Capucci A, et al. Dynamic electrophysiologic behavior of human atria during paroxysmal atrial fibrillation. Circulation 1995; 92: 1193 - 1202
10. Biffi M, et al. Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relationship with arrhythmia termination. Heart 1999;82:176-182
11. Biffi M, et al. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiologic parameters. Heart 2002; 87:443-448
12. Manios EG, et al. Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence. Cardiovascular Research 2000;47:244-253
13. Tieleman RG, et al. Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation 1997;95:1945-53
14. Goette A, et al. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation 1996;94:2968-74
15. Daoud EG, et al. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-1550
16. Tieleman RG, et al. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria. J Am Coll Cardiol 1998;31:167-173
17. Lee SH, et al. Effect of verapamil on long term tachycardia-induced atrial electrical remodeling. Circulation 2000;101:200-206
18. Kumagai K, et al. Effects of verapamil on electrophysiological properties in paroxysmal atrial fibrillation. PACE 1993;16:309-316
19. Elvan A, et al. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs: electrphysiologic remodeling. Circulation 1996;94:2953-60
20. Gaspo R, et al. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96:4027-35
21. Morillo CA, et al. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-95
22. Fareh S, et al. The T-type Ca2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs. Circulation 1999;100:2191-97
23. Fareh S, et al. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced remodeling in dogs. Cardiovasc Res 2001;49:762-770
24. Kannel WB et al. Epidemiologic features of atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22
25. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998;37:279-289
26. Flesch M, et al. Evidence for a functional relevance of an enhanced expression of the Na+-Ca++ exchanger in failing human myocardium. Circulation 1996;94:992-1002
27. Pogwizd SM, et al. Upregulation of Na+-Ca++ exchanger expression and function in an arrhythmogenic rabbit model of heart failure Circ Res 1999;85:1009-1019
28. Hobai IA, et al. Enhanced Ca++-activated Na+-Ca++ exchange activity in canine pacing-induced herat failure Circ Res 2000;87:690-698
29. Pogwizd SM, et al. Arrhythmogenesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001;88:1159-67
30. Danshi Li, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000;101:2631-38
31. Danshi Li, et al Contrasting efficacy of dofetilide in differing experimental models of atrial fibrillation. Circulation 2000;102:104-112
32. Torp-Pedersen C, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 1999;341:857-865
33. Shinigawa K, et al. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs. Circulation 2002;105:2672-78
34. Danshi Li, et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001104:2608-14